Investigation Overview
Oct. 09, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in China Nuokang Bio-Pharmaceutical Inc. (NASDAQ:NKBP) shares was announced concerning whether the takeover offer to acquire China Nuokang Bio-Pharmaceutical Inc. and the takeover process are unfair to investors in NASDAQ:NKBP shares. The investigation by a law firm concerns whether certain officers an...
You must register (for free) or login to view the entire investigation.